MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2024-25)
- Udyam number
- UDYAM-MH-33-0053831
Amtrax (India) Life Sciences Private Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹100.75 Cr
▼ 8% YoY
Net profit · FY 2025
₹66.27 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹5.41 Cr
EBITDA margin 5.4%
Authorised capital
₹2 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹33.11 Cr
Satisfied ₹38.22 Cr
Company age
14 yrs
Est. 2012
Directors on board
3
As per MCA filings
About Amtrax (India) Life Sciences Private Limited
Data last updated:
Amtrax (India) Life Sciences Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 09 April 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U74120MH2012PTC229327. Its GSTIN is 27AAMCA5824H1ZI (Maharashtra).
The company has an authorised share capital of ₹2 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Kunjeshkumar Shanalal Shah and Arvind Bhau Patil.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Amtrax House Unit No.04 Cts No. 407/B Nr. Keshav Shrushti Bldg L.B S Marg Bhandup (West), Mumbai, Maharashtra, India – 400078.
As per the financials filed for FY 2025, the company reported a revenue of ₹100.75 Cr, a decline of 8% compared to the previous year. For the same year it recorded a net profit of ₹66.27 Lakh (net margin 0.7%) and EBITDA of ₹5.41 Cr (EBITDA margin 5.4%). Revenue has grown at a compounded annual rate (CAGR) of 6% over five years.
The company is associated with 1 brand: Amtrax Labortaries. As per MCA filings, the company has open charges of ₹33.11 Cr and satisfied charges of ₹38.22 Cr on record. Court records list 2 cases involving the company, including 2 filed against it. The company has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in March 2024. Its 7 peer companies in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 4 larger and 3 smaller; the largest is Hitarth Enterprises Private Limited with revenue of ₹103.65 Cr.
Amtrax (India) Life Sciences Private Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0053831). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website amtraxindia.in.
Company details
CIN U74120MH2012PTC229327
Registration Number 229327
Incorporation Date 09 April 2012
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2024
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-MH-33-0053831
Key People
Kunjeshkumar Shanalal Shah Director Arvind Bhau Patil Director Pravin Shetty Shyam Director Recognitions & Rankings of Amtrax (India) Life Sciences
Contact details
Amtrax (India) Life Sciences Private Limited's registered office is in Mumbai, Maharashtra. Its website is amtraxindia.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressAmtrax House Unit No.04 Cts No. 407/B Nr. Keshav Shrushti Bldg L.B S Marg Bhandup (West), Mumbai, Maharashtra, India – 400078
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Amtrax (India) Life Sciences Private Limited, buy the company report.
Comprehensive company report
Amtrax (India) Life Sciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Amtrax (India) Life Sciences operates one associated brand: Amtrax Labortaries. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Delivers comprehensive marketing services for the pharmaceutical sector. | amtraxindia.in |
Business activity
The main business activity of Amtrax (India) Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Amtrax (India) Life Sciences Private Limited, buy the company report.
Financials of Amtrax (India) Life Sciences Private Limited
FY 2024 filings availableAmtrax (India) Life Sciences Private Limited reported revenue of ₹100.75 Cr (down 8% YoY) for FY 2025.
Revenue · FY 2025
₹100.75 Cr ▼ 8%
Net profit · FY 2025
₹66.27 Lakh margin 0.7%
EBITDA · FY 2025
₹5.41 Cr margin 5.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 8%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 13%
3 years · compounded
▲ 23%
5 years · compounded
▲ 14%
Revenue fell 8% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 6%. EBITDA rose 13% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.41 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹66.27 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Amtrax (India) Life Sciences Private Limited, buy the company report.
Board of directors of Amtrax (India) Life Sciences Private Limited
Amtrax (India) Life Sciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Kunjeshkumar Shanalal Shah | Director | 12 Feb 2015 | 11 Years 8 Months | Current |
| Arvind Bhau Patil | Director | 09 Apr 2012 | 14 Years 6 Months | Current |
| Pravin Shetty Shyam | Director | 09 Apr 2012 | 14 Years 6 Months | Current |
Peer comparison
Amtrax (India) Life Sciences Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Hitarth Enterprises Private Limited | ₹103.65 Cr (FY 2024) | 56.0% | New Delhi, Delhi, India | |||
| Rich Faith Ventures Private Limited | ₹103.41 Cr (FY 2025) | 1734395.0% | New Delhi, Delhi, India | |||
| G.S.Pharmaceutical Distributors Private Limited | ₹103.17 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Arzt and Health Private Limited | ₹103.08 Cr (FY 2022) | 152.0% | Mumbai, Maharashtra, India | |||
| Amtrax (India) Life Sciences Private Limitedthis company | ₹100.75 Cr (FY 2025) | ₹66.27 Lakh | 0.7% | -8.0% | Mumbai, Maharashtra, India | |
| Euro Lifecare Private Limited | ₹100.42 Cr (FY 2025) | -1.0% | Mumbai, Maharashtra, India | |||
| Arham Drugs and Chemicals Private Limited | ₹100.31 Cr (FY 2024) | 119.0% | Mumbai, Maharashtra, India | |||
| Antex Pharma Private Limited | ₹98.92 Cr (FY 2024) | 23.0% | Delhi, India |
To see the full peer comparison of Amtrax (India) Life Sciences Private Limited, buy the company report.
Auditor
Amtrax (India) Life Sciences Private Limited is audited by ATUL SHAH & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ATUL SHAH & ASSOCIATES | FY 2023 | 100783W |
Shareholding
The shareholding of Amtrax (India) Life Sciences Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Amtrax (India) Life Sciences Private Limited, buy the company report.
Charges & borrowings
Open charges
₹33.11 Cr
Satisfied charges
₹38.22 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Oct 2025 | 101184870 | Standard Chartered Bank | ₹16 Cr | Open | |
| 17 Oct 2025 | 101184875 | Standard Chartered Bank | ₹20 Lakh | Open | |
| 16 Oct 2025 | 101181087 | Others | ₹16.45 Cr | Open | |
| 16 Jul 2024 | 100958668 | Others | ₹31.76 Lakh | Open | |
| 22 Jul 2022 | 100601822 | Others | ₹14.57 Lakh | Open |
To see the full charge records of Amtrax (India) Life Sciences Private Limited, buy the company report.
Total charge records: 12 View all charges
Deals & funding
Amtrax (India) Life Sciences Private Limited has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in March 2024.
Total deals
4
Funding rounds
2
Rights issue
1
Secondary share transfer
1
Disclosed funding
₹64 Lakh
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Rights issue | ₹35 Lakh | Investors: 3 individuals |
| Mar 2021 | Funding round | ₹35 Lakh | Investors: 3 individuals |
| Oct 2018 | Funding round | ₹29 Lakh | Investors: 3 individuals |
| Feb 2017 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Amtrax (India) Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed.
Total cases
2
Filed against the company
2
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 2 | 2 | 0 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, MAHARASHTRA | Court case (CARAP) | Filed against the company by Nectar Prints Pvt Ltd | Disposed |
| High Court, MAHARASHTRA | Court case (CARBP) | Filed against the company by Nectar Prints P Ltd | Disposed |
To see the full case history of Amtrax (India) Life Sciences Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Amtrax (India) Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Amtrax (India) Life Sciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAMCA5824H1ZI | Maharashtra | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Amtrax (India) Life Sciences Private Limited, buy the company report.
Recent activity
Amtrax (India) Life Sciences Private Limited has 6 board changes on record since 2012: 3 appointments and 3 cessations. The latest: Kunjeshkumar Shanalal Shah ceased to be Additional Director on 30 Sep 2015.
Charges
A charge registered on 04 May 2024 via Charge ID 100916796 with Others was fully satisfied on 29 Oct 2025.
Charges
A charge registered on 13 Nov 2020 via Charge ID 100396714 with Others was fully satisfied on 29 Oct 2025.
Charges
A charge with Standard Chartered Bank amounted to Rs. 16.00 Cr with Charge ID 101184870 was registered on 17 Oct 2025.
Charges
A charge with Standard Chartered Bank amounted to Rs. 0.20 Cr with Charge ID 101184875 was registered on 17 Oct 2025.
Charges
A charge with Others amounted to Rs. 16.45 Cr with Charge ID 101181087 was registered on 16 Oct 2025.
AGM
Amtrax (India) Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 0.32 Cr with Charge ID 100958668 was registered on 16 Jul 2024.
Charges
A charge with Others amounted to Rs. 1.00 Cr with Charge ID 100916796 was registered on 04 May 2024.
Filing
Amtrax (India) Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.
Charges
A charge with Others of Rs. 23.87 Cr registered on 13 Nov 2020 with Charge ID 100396714 was modified on 30 Aug 2023.
Charges
A charge with Others amounted to Rs. 0.15 Cr with Charge ID 100601822 was registered on 22 Jul 2022.
Charges
A charge registered on 28 Feb 2022 via Charge ID 100546020 with Others was fully satisfied on 22 Jun 2022.
18 earlier events are in the company report.
Frequently asked questions
Amtrax (India) Life Sciences is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 09 April 2012 (14+ years old) and is registered under CIN U74120MH2012PTC229327.
Amtrax (India) Life Sciences has 3 current directors:
- Kunjeshkumar Shanalal Shah - Director
- Arvind Bhau Patil - Director
- Pravin Shetty Shyam - Director
The latest financial statements of Amtrax (India) Life Sciences on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Amtrax (India) Life Sciences is 27AAMCA5824H1ZI, registered in Maharashtra.
The CIN (Corporate Identification Number) of Amtrax (India) Life Sciences is U74120MH2012PTC229327. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Amtrax (India) Life Sciences has 2 court cases on record: 2 filed against it.
Amtrax (India) Life Sciences was incorporated on 09 April 2012, making it 14+ years old. It is registered with the Registrar of Companies, Mumbai.
Amtrax (India) Life Sciences has 4 deals on record (2 funding rounds, 1 rights issue, 1 secondary share transfer), with disclosed funding of ₹64 Lakh; the latest was in March 2024.
The peers of Amtrax (India) Life Sciences by revenue are Hitarth Enterprises Private Limited, Rich Faith Ventures Private Limited, G.S.Pharmaceutical Distributors Private Limited, Arzt and Health Private Limited, Euro Lifecare Private Limited and 2 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Kunjeshkumar Shanalal Shah ceased to be Additional Director on 30 Sep 2015. Hiralal Chandrakant Magaji ceased to be Director on 12 Feb 2015. Kunjeshkumar Shanalal Shah was appointed as Director on 12 Feb 2015. Amtrax (India) Life Sciences has 6 board changes on record in total.
Yes, Amtrax (India) Life Sciences is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-33-0053831).